Pramodini Medicare (NSE:PRAMODINI) Revenue: ₹178.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:PRAMODINI Pramodini Medicare Ltd NSE:PRAMODINI
19 GF Score
Price ₹114.80
! 1 Warning Sign
View Full Analysis

What is Pramodini Medicare Revenue?

Pramodini Medicare NSE:PRAMODINI -2.01% 19 Revenue is ₹178.3 Mil as of Mar. 2026. GuruFocus rates NSE:PRAMODINI with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Pramodini Medicare's revenue for the three months ended in Mar. 2026 was ₹178.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹178.3 Mil. Pramodini Medicare's Revenue per Share for the three months ended in Mar. 2026 was ₹8.09. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.09.

During the past 12 months, the average Revenue per Share Growth Rate of Pramodini Medicare was 62.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 26.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Pramodini Medicare's highest 3-Year average Revenue per Share Growth Rate was 26.80% per year. The lowest was 26.80% per year. And the median was 26.80% per year.


Pramodini Medicare  (NSE:PRAMODINI) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Pramodini Medicare Revenue Related Terms


Pramodini Medicare Revenue Historical Data

* Premium members only.

The historical data trend for Pramodini Medicare's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pramodini Medicare Revenue Chart

Pramodini Medicare Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Revenue
305.81 352.30 382.38 622.88

Pramodini Medicare Quarterly Data
Mar23 Mar24 Mar25 Dec25 Mar26
Revenue 0.00 0.00 0.00 0.00 178.35

NSE:PRAMODINI vs HCA, THC, EHC: Revenue Comparison

For the Medical Care Facilities subindustry, Pramodini Medicare's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pramodini Medicare Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pramodini Medicare's Revenue distribution charts can be found below:

* The bar in red indicates where Pramodini Medicare's Revenue falls into.


NSE:PRAMODINI
19GF Score
Pramodini Medicare Ltd NSE:PRAMODINI
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pramodini Medicare Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹178.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₹178.3 Mil mean?
Pramodini Medicare (NSE:PRAMODINI) has a Revenue of ₹178.3 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Pramodini Medicare and its competitors.
Is Pramodini Medicare's Revenue too high?
Pramodini Medicare's current Revenue is ₹178.3 Mil. Overall, Pramodini Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pramodini Medicare's Revenue compare to HCA and THC?
Pramodini Medicare's Revenue of ₹178.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Pramodini Medicare and its competitors. Pramodini Medicare's current Revenue is ₹178.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pramodini Medicare stock overvalued right now?
Pramodini Medicare (NSE:PRAMODINI) has a current Revenue of ₹178.3 Mil. The current Revenue is ₹178.3 Mil. Pramodini Medicare's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Pramodini Medicare (NSE:PRAMODINI), the current Revenue is ₹178.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pramodini Medicare Business Description

Address Prakasam Road, D. No: - 29-4-54K, CSI Complex, Suryaraopet, Vijayawada, AP, IND, 520002
Pramodini Medicare Ltd is a diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine service to public hospitals, private hospitals, certain PSU (Public Sector Undertaking) of Government of India and medical colleges across tier I, tier II and tier III cities throughout India. The company also provide teleradiology services, which functions on a 24*7 basis throughout the year. It provides healthcare services for core testing, patients diagnosis, disease prevention and monitoring of various health conditions. Its services includes both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases.
19GF Score

Get the complete analysis for NSE:PRAMODINI

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹114.80
Price